Seattle has seen a strong string of IPOs in the past few years — from Zillow to Tableau to Zulily. Now, a Seattle biotechnology company is hoping to make its… Read More
In one of the largest venture capital rounds in the state so far this year, Bothell’s Alder BioPharmaceuticals has raised $38 million to support ongoing research for its cancer and migraine… Read More